Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly [MSNBC.com]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: MSNBC.com
Biotech and PharmaDanish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, LillyPublished Thu, Dec 11 2025Elsa OhlenWATCH LIVEKey PointsCelsopupo | Istock | Getty ImagesNovo NordiskEli LillyThe new strategy, "Metabolic Frontier 2030," comes as Zealand shares have dropped 29% year to date as investors are betting the market will fragment, with fewer singular winners than they were 18 months ago at the peak of the weight loss drug frenzy.Ahead of its Capital Markets Day on Thursday, the Danish drugmaker said it now targets five drug launches, at least 10 clinical pipeline programs and industry-leading cycle times by 2030.The strategy will combine strategic partnerships, accelerated drug development, and expanded research capabilities to build the world's most valuable metabolic health pipeline, Zealand Pharma said in a statement.One of Zealand's most promising drugs under development is petrelintide which targets the pancreatic amylin hormone — differ
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- Eli Lilly and Company (NYSE:LLY) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..MarketBeat
- Eli Lilly and Company (NYSE:LLY) had its price target lowered by analysts at Bank of America Corporation from $1,286.00 to $1,268.00. They now have a "buy" rating on the stock.MarketBeat
- Eli Lilly: Short-Term Upside Exhausted (Rating Downgrade) [Seeking Alpha]Seeking Alpha
- Eli Lilly and Company (NYSE:LLY) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $951.00 to $1,145.00. They now have a "buy" rating on the stock.MarketBeat
- Eli Lilly's Next-Generation Obesity Drug Secures First Phase III Win [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 12/8/25 - Form 3
- 11/26/25 - Form 4
- 11/26/25 - Form 4
- LLY's page on the SEC website